Acanthamoeba Keratitis
Acanthamoeba Keratitis (AK), also known as Acanthamoeba eye infection, is a serious parasitic corneal infection. This page provides information on AK diagnosis, clinical documentation, and medical coding for healthcare professionals. Learn about signs, symptoms, treatment, and ICD-10 codes related to Acanthamoeba Keratitis for accurate medical records and billing.
Rare but serious parasitic infection of the cornea.
Severe eye pain, redness, blurred vision, light sensitivity, and excessive tearing.
Contact lens wearers, especially those using tap water or homemade solutions for lens care.
ICD-10 Code Families
Complete code families applicable to B60.11
When to use each related code
| Description | When to use |
|---|---|
| Rare but serious eye infection. | Contact lens wearers with eye pain, redness, blurred vision, light sensitivity. Suspect exposure to contaminated water. |
| Corneal inflammation, often from bacteria or viruses. | Eye pain, redness, tearing, blurred vision. Consider bacterial, viral, or other causes based on symptoms and history. |
| Fungal eye infection, can be severe. | Eye pain, redness, discharge, blurred vision. History of eye injury, especially with plant material, or weakened immune system. |
Best-practice checklist
- ✓Acanthamoeba Keratitis (AK) diagnosis: Document source of infection.
- ✓AK diagnosis: Describe corneal findings (e.g., infiltrates, ulcers).
- ✓AK diagnosis: Detail patient's contact lens use history.
- ✓AK diagnosis: Specify diagnostic tests (e.g., confocal microscopy, culture).
- ✓AK diagnosis: Note treatment plan (e.g., topical biguanides, diamidines).
Common pitfalls to avoid
AK symptoms mimic conjunctivitis, leading to incorrect coding with less specific ICD-10 codes like H10, impacting reimbursement and quality metrics.
Failing to specify laterality (right, left, bilateral) with ICD-10 codes (e.g., H19.011, H19.012, H19.013) for AK can lead to claim denials.
Insufficient documentation of AK diagnosis, including causative organism and severity, hinders accurate coding and compliance audits, affecting CDI efforts.
Best-practice tips
- 01Minimize contact lens contamination: proper cleaning, storage, and handling.
- 02Avoid swimming, showering, or using hot tubs while wearing contacts.
- 03Use sterile contact lens solutions; avoid tap water exposure.
- 04Regular eye exams crucial for early AK diagnosis and treatment.
- 05Prompt medical attention for eye pain, redness, or blurred vision.
Step-by-step checklist
- 1
Hx: Contact lens use, exposure to contaminated water?
- 2
Sx: Severe eye pain, photophobia, blurred vision?
- 3
Dx: Confocal microscopy or PCR for Acanthamoeba?
- 4
Rx: Biguanide, diamidine, or antifungal agents?
- 5
Document: ICD-10 code B00.1, Acanthamoeba keratitis
Ready-to-paste narrative
Patient presents with complaints consistent with Acanthamoeba keratitis (AK), also known as Acanthamoeba eye infection. Symptoms include severe eye pain, photophobia, foreign body sensation, excessive tearing, and blurred vision. On examination, the patient exhibits corneal edema, stromal infiltrates, and a characteristic ring-shaped infiltrate in the cornea. Slit-lamp examination reveals corneal neovascularization and in some cases, a hypopyon. The patient reports a history of contact lens use, specifically mentioning overnight wear and inadequate lens hygiene practices, a known risk factor for Acanthamoeba keratitis. Differential diagnosis includes fungal keratitis, herpetic keratitis, and bacterial keratitis. Diagnosis of Acanthamoeba keratitis is confirmed via corneal scraping and confocal microscopy demonstrating the presence of Acanthamoeba trophozoites or cysts. Treatment plan includes topical application of biguanide disinfectants such as polyhexamethylene biguanide (PHMB) and chlorhexidine, often in combination with a diamidine like propamidine isethionate. Patient education regarding contact lens hygiene, including proper cleaning, disinfection, and storage, is crucial. Follow-up appointments are scheduled for close monitoring of treatment response and to assess for potential complications such as corneal scarring and permanent vision loss. ICD-10 code B00.2 will be used for billing purposes. The prognosis is guarded, with potential for significant visual impairment if treatment is delayed or inadequate. The patient is advised to discontinue contact lens wear until the infection is resolved and re-evaluated for contact lens wear suitability at a later date.
Common questions and answers
What are the most effective diagnostic techniques for differentiating Acanthamoeba Keratitis (AK) from other corneal infections like fungal keratitis or Herpes Simplex Keratitis?+
Differentiating Acanthamoeba Keratitis (AK) from other corneal infections requires a multifaceted approach. While clinical presentation can offer initial clues, definitive diagnosis relies on laboratory confirmation. Confocal microscopy, demonstrating characteristic double-walled cysts or trophozoites within the cornea, is highly specific for AK. Corneal scraping for culture on non-nutrient agar with *E. coli* overlay is the gold standard for diagnosis, but it can take several days to yield results. PCR-based assays offer faster and more sensitive detection of Acanthamoeba DNA. Consider implementing PCR testing in cases with high clinical suspicion of AK where confocal microscopy is unavailable. In challenging cases, comparing clinical features, including ring infiltrates, perineural infiltrates, and radial keratoneuritis, alongside laboratory results, aids in distinguishing AK from fungal keratitis or Herpes Simplex Keratitis. Explore how combining diagnostic modalities improves accuracy and speeds up treatment initiation for AK.
How should I manage Acanthamoeba Keratitis (AK) pain in patients, given its often severe and debilitating nature?+
Managing Acanthamoeba Keratitis (AK) pain effectively requires addressing both the underlying infection and the associated inflammation and neuropathic pain. Topical anti-inflammatory agents, such as corticosteroids, may be used judiciously under close monitoring as they can exacerbate the infection in some cases. Systemic analgesics, including NSAIDs and opioids, can be prescribed for moderate to severe pain relief. For debilitating neuropathic pain, consider implementing topical or oral agents such as gabapentin or pregabalin. Adjunctive therapies like topical cycloplegics can help relieve ciliary spasm and photophobia. Furthermore, addressing any underlying dry eye associated with AK through lubricating eye drops can improve patient comfort. Learn more about pain management strategies in AK to ensure optimal patient outcomes.
What are the recommended first-line treatment options for Acanthamoeba Keratitis (AK), and how should treatment be adjusted based on disease severity and patient response?+
First-line treatment for Acanthamoeba Keratitis (AK) typically involves biguanide antiseptics, such as polyhexamethylene biguanide (PHMB) and chlorhexidine. These are often combined with a diamidine, like propamidine isethionate or hexamidine. Treatment frequency and duration depend on disease severity and clinical response. For early-stage AK, topical therapy every 1-2 hours may be sufficient. In severe cases, hourly administration or even combination therapy with oral miltefosine may be necessary. Close monitoring of patient response is essential. If the infection does not respond to initial therapy within a few weeks, consider implementing alternative treatment strategies or consulting with a corneal specialist. Explore how tailored treatment approaches based on disease stage and patient response can optimize outcomes in AK.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.